Molecular heterogeneity in histomorphologic subtypes of lung adeno carcinoma represents a challenge for treatment decision
Lung cancer is the leading cause in cancer related death, with non-small cell lung cancer (NSCLC) being the most frequent subtype. The importance of NSCLC is reflected by the various targeted therapy options especially for NSCLC adenocarcinomas (lung adeno carcinoma (LUAD)) as well as a set of optio...
Main Authors: | Tobias Kolb, Sarah Müller, Peter Möller, Thomas F.E. Barth, Ralf Marienfeld |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558623000787 |
Similar Items
-
Heterogeneous expression of predictive biomarkers PD-L1 and TIGIT in non-mucinous lung adenocarcinoma and corresponding lymph node metastasis: A challenge for clinical biomarker testing
by: Tobias Kolb, et al.
Published: (2023-04-01) -
TMB in NSCLC: A Broken Dream?
by: Sara Bravaccini, et al.
Published: (2021-06-01) -
Pan-cancer analysis of the prognostic and immunological role of GJB2: a potential target for survival and immunotherapy
by: Yuting Jia, et al.
Published: (2023-06-01) -
Pan-cancer analyses reveal IGSF10 as an immunological and prognostic biomarker
by: Yongxia Zhou, et al.
Published: (2023-01-01) -
Immunotherapy in small bowel adenocarcinoma: a potential role?
by: Francesco Vitiello, et al.
Published: (2024-01-01)